News

Morgan Stanley sees Eli Lilly taking share before semaglutide's patents even become the bigger issue.

Palantir Stock Gets a Major Boost: DA Davidson Raises Price Target to $250

The next AI trade may extend well beyond GPUs.

JPMorgan cuts Chewy stock price target to $24. Here’s why analyst Doug Anmuth recommends caution when playing CHWY shares.

UiPath (PATH) sells software that brings AI agents, robots, and people together to run business processes. Its Q2 FY2027 results beat management's guidance and the fiscal 2027 outlook went up, yet the shares fell 16.6% on September 4, the first trading day after the report, while the S&P 500 slipped 0.4%. The earnings call also carried an analyst's question about a new AI model said to be far better at workflow jobs.

Bank of America just published its verdict, and it cuts both ways.

According to TheFly, UBS cut its price target on SMR stock to $6 from $10, implying a 41% downside potential from the previous close.

Anmuth sets a December 2027 target of $24 on seven times 2028 EBITDA

Morgan Stanley Cuts Novo Nordisk to Underweight as Semaglutide Risks Cloud Outlook

The precision-engineering group climbed after Bank of America jumped from bearish to bullish, arguing that semiconductor, electronics and aerospace demand is running well ahead of expectations.

Two analyst downgrades in back-to-back sessions have Chewy stock cratering while the broader market climbs, and the reasoning behind both cuts points to a force that Chewy's own strong execution simply cannot overcome.

Northland upgraded Intel to “Outperform” with a $120 target on Sept. 8, citing turnaround progress and tight server-CPU supply after shares jumped nearly 15% over five sessions.

Dell has surged over 300% this year on the back of a $95 billion AI backlog, but profit takers just hit the brakes hard. Whether the next leg up reaches a bold new price target depends on three specific dominoes falling into place.

Chewy downgraded, Shopify initiated: Wall Street's top analyst calls

Wedbush gave CrowdStrike shares an ‘Outperform’ rating and a $250 price target.

Investing.com -- JPMorgan downgraded Chewy to Neutral from Overweight in a note on Friday, citing persistent macroeconomic pressure on the online pet retailer's organic growth even as the company executes well on its own initiatives.

One name in this trio has raised its dividend every single year since 1974, but the other two still make a compelling case for your income portfolio despite very different risks lurking beneath their payouts.

Billionaire Elon Musk-led Space Exploration Technologies Corp. has revealed the Starlink satellite internet service’s fourth-generation router, promising better connectivity and water-resistant port covers, among other updates, More Coverage Area In a post on the social media platform X, Starlink’s official...

Dell’s $95 billion AI server backlog is fueling the next leg of the stock’s rally.

Wall Street’s view of Meta is shifting as the company pushes deeper into artificial intelligence and looks for its next major source of growth.

Arete Research downgrades Uber stock to "Neutral." Here’s why analyst Oliver Lester warned that there’s little to no further upside left in UBER shares.

Wells Fargo raises price target on Synopsys stock to $475. Here’s what made analyst Joe Quatrochi upgrade SNPS shares today.

Apple's biggest product surprise comes with an uncomfortable earnings tradeoff

Enbridge's scale, diversification, and durable dividend make it a solid investment.

The bank’s revised forecast says something uncomfortable about today’s price.

Can an extra $100 on the starting price outrun memory costs management itself expects to keep climbing?

KB Financial (KB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Planet Labs PBC (PL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

StoneX analyst Mark Palmer upgraded Block to ‘Buy’ from ‘Hold’ and set a $105 price target, citing progress from the company’s AI-focused reorganization.

Meta stock is a buy after the strong initial reaction to its Muse AI app, according to analysts at JPMorgan.